Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts

EMBO Journal

Volumn 22, Issue 15, 2003, Pages 3992-4002

  Baus, Fabienne ^a,b   Gire, Véronique ^a   Fisher, Daniel ^c   Piette, Jacques ^b,d   Dulić, Vjekoslav ^a  

^a Centre National de la Recherche Scientifique   (France)

^b INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

^c INSTITUTE OF HUMAN GENETICS   (France)

^d INSERM   (France)

Author keywords

Bleomycin; Decatenation; G2 checkpoint; HPV E6 and E7; ICRF 193

Indexed keywords

CYCLIN A; CYCLIN B1; CYCLIN DEPENDENT KINASE 2; DNA; PROTEIN; PROTEIN CDK1; PROTEIN P21; TOXIC SUBSTANCE; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL DEATH; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINESIS; DNA DAMAGE; FIBROBLAST; GENOTOXICITY; HUMAN; HUMAN CELL; MITOSIS; MITOSIS INHIBITION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

BLEOMYCIN; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; DNA DAMAGE; FIBROBLASTS; G2 PHASE; HUMANS; MITOSIS; PIPERAZINES;

EID: 0042025008     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/cdg387     Document Type: Article

References (38)

1. Abraham, R.T. (2001) Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev., 15, 2177-2196.
2. 1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl Acad. Sci. USA, 92, 8493-8497.
3. 1 arrest in resulting tetraploid cells. Cancer Res., 61, 7660-7668.
4. 1. Mol. Biol. Cell, 12, 1315-1328.
5. Borel, F., Lohez, O.D., Lacroix, F.B. and Margolis, R.L. (2002) Multiple centrosomes arise from tetraploidy checkpoint failure and mitotic centrosome clusters in p53 and RB pocket protein-compromised cells. Proc. Natl Acad. Sci. USA, 99, 9819-9824.
6. 2 arrest after DNA damage. Science, 282, 1497-1501.
7. Dazard, J.-E. (2000) Rôle régulateur des protéines p53 et Mdm2 au cours de la différenciation terminale kératinocytaire. PhD thesis, Université de Montpellier I, France.
8. Deming, P.B., Cistulli, C.A., Zhao, H., Graves, P.R., Piwnica-Worms, H., Paules, R.S., Downes, C.S. and Kaufmann, W.K. (2001) The human decatenation checkpoint. Proc. Natl Acad. Sci. USA, 98, 12044-12049.
9. Dimri, G.P. et al. (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA, 92, 9363-9367.
10. 2 cycle checkpoint in mammalian cells. Nature, 372, 467-470.
11. 1 arrest. Cell, 76, 1013-1023.
12. 2/M-phase transition. Mol. Cell. Biol., 18, 546-557.
13. Dulić, V., Beney, G.E., Frebourg, G., Drullinger, L.F. and Stein, G.H. (2000) Uncoupling between phenotypic senescence and cell cycle arrest in aging p21-deficient fibroblasts. Mol. CelL Biol., 20, 6741-6754.
14. 2 checkpoint is retinoblastoma protein dependent, Mol. Cell. Biol., 20, 4210-4223.
15. Furuno, N., den Elzen, N. and Pines, J. (1999) Human cyclin A is required for mitosis until mid prophase. J. Cell Biol., 147, 295-306.
16. Gottifredi, V., Karni-Schmidt, O., Shieh, S.S. and Prives, C. (2001) p53 down-regulates CHK1 through p21 and the retinoblastoma protein. Mol. Cell. Biol., 21, 1066-1076.
17. Grana, X., Garriga, J. and Mayol, X. (1998) Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth. Oncogene, 17, 3365-3383.
18. 2 phase roles for Cdk2 revealed by inducible expression of a dominant-negative mutant in human cells. Mol. Cell. Biol., 21, 2755-2766.
19. Ishida, R., Sato, M., Narita, T., Utsumi, K.R., Nishimoto, T., Morita, T., Nagata, H. and Andoh, T. (1994) Inhibition of DNA topoisomerase II by ICRF-193 induces polyploidization by uncoupling chromosome dynamics from other cell cycle events. J. Cell Biol., 126, 1341-1351.
20. 2 checkpoint response in diploid human fibroblasts. Mutat. Res., 400, 153-167.
21. Lodygin, D., Menssen, A. and Hermeking, H. (2002) Induction of the Cdk inhibitor p21 by LY83583 inhibits tumor cell proliferation in a p53independent manner. J. Clin. Invest., 110, 1717-1727.
22. Lowe, S.W., Schmitt, E.M., Smith, S.W., Osborne, B.A. and Jacks, T. (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature, 362, 847-849.
23. Mantovani, F. and Banks, L. (2001) The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene, 20, 7874-7887.
24. Munger, K., Basile, J.R., Duensing, S., Eichten, A., Gonzalez, S.L., Grace, M. and Zacny, V.L. (2001) Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene, 20, 7888-7898.
25. Ohi, R. and Gould, K.L. (1999) Regulating the onset of mitosis, Curr. Opin. Cell Biol., 11, 267-273.
26. Pagano, M., Pepperkok, R., Verde, F., Ansorge, W. and Draetta, G. (1992) Cyclin A is required at two points in the human cell cycle. EMBO J., 11, 961-971.
27. 2 checkpoint is maintained by redundant pathways. Mol. Cell. Biol., 19, 5872-5881.
28. 2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science, 277, 1501-1505.
29. 2/M checkpoints. Genes Dev., 16, 245-256.
30. 1 control and immortalization. Genes Dev., 14, 3037-3050.
31. Scheffner, M., Huibregtse, J.M., Vierstra, R.D. and Howley, P.M. (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell, 75, 495-505.
32. 1-phase progression. Genes Dev., 13, 1501-1512.
33. 2 DNA damage checkpoint. J. Biol. Chem., 275, 30638-30643.
34. Waf1/Cip1 inhibition of cyclin E/Cdk2 activity prevents endoreduplication after mitotic spindle disruption. Mol. Cell. Biol., 19, 205-215.
35. 2/M transition by p53. Oncogene, 20, 1803-1815.
36. Taylor, W.R., Schonthal, A.H., Galante, J. and Stark, G.R. (2001) p130/E2F4 binds to and represses the cdc2 promoter in response to p53. J. Biol. Chem., 276, 1998-2006.
37. 2 arrest in human cells. Oncogene, 17, 673-684.
38. Yang, J., Bardes, E.S., Moore, J.D., Brennan, J., Powers, M.A. and Kornbluth, S. (1998) Control of cyclin B1 localization through regulated binding of the nuclear export factor CRM1. Genes Dev., 12, 2131-2143.